Skye Bioscience, Inc. (SKYE)
0.9605
-0.01
(-1.27%)
USD |
NASDAQ |
Jan 21, 13:28
Skye Bioscience Market Cap: 30.79M for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Perspective Therapeutics, Inc. | 185.84M |
| Theravance Biopharma, Inc. | 1.026B |
| Viking Therapeutics, Inc. | 3.728B |
| Kyntra Bio, Inc. | 34.56M |
| Myomo, Inc. | 36.79M |
Market Cap Related Metrics
| PEG Ratio | -0.0140 |
| Price to Book Value | 0.9377 |
| Price | 0.9605 |
| Earnings Yield | -134.3% |
| PEGY Ratio | -0.0140 |